http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112020006150-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e7c3576cf4bfaf1203a9086e6b2ea21 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2018-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_148e8ad5c085f5caaa3893fcd079c8f4 |
| publicationDate | 2020-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-112020006150-A2 |
| titleOfInvention | anticancer peptides and their uses |
| abstract | the present invention provides a peptide of formula (i) or a pharmaceutically acceptable salt thereof, wherein the n-terminal group of the peptide is a monoradical of formula? nhr1; the terminal group c of the peptide is a monoradical of formula? c (o) -r2; r1 is a monoradical selected from hydrogen and? c (o) - (c1-c20) alkyl; r2 is a monoradical selected from -oh and radical? nr3r4; r3 and r4 are independently selected from hydrogen and (c1-c10) alkyl; a to j are integers from 0 to 1, provided that at least one of a to j is 1; and x1 represents any amino acid. the present invention also provides conjugates and compositions comprising the peptide of formula (i). |
| priorityDate | 2017-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 331.